Minaris Advanced Therapies

End-to-End Cell Therapy Manufacturing / Viral Vector Supply / Testing – CDMO

Goals & Objectives

Minaris Advanced Therapies was formed through the merger of WuXi Advanced Therapies and Minaris Regenerative Medicine, following acquisition by Altaris Capital Partners. With the newly merged entity poised to become a global leader, the company needed a new name, identity, and strategy to reflect its expanded capabilities and global vision.